DCE-MRI不同期相影像组学预测乳腺癌肿瘤浸润淋巴细胞水平
该回顾性研究纳入133例病理证实乳腺癌患者,在T2WI、DWI及DCE-MRI各期相手动勾画病灶并提取6250个定量特征,采用LASSO筛选特征并构建四类影像组学模型预测TIL水平。延迟期(尤其DCE_P6)特征预测性能占优,融合多序列影像组学模型与联合临床模型AUC分别达0.934和0.950,差异无统计学意义。
要点
- DCE-MRI延迟期(尤其DCE_P6)影像组学特征对TIL水平的预测价值优于其他期相。
- 融合多序列影像组学模型与联合临床模型预测TIL的AUC分别达0.934和0.950。
- 基于MRI的影像组学列线图可有效预测乳腺癌TIL水平。
核心结论
- DCE-MRI影像组学模型,尤其基于延迟期提取的特征,有助于提高预测乳腺癌TIL水平的性能。
- 融合多序列影像组学模型与联合临床模型预测性能最高,AUC分别为0.934和0.950,但两者差异无统计学意义。
研究设计与样本
- 回顾性研究,收集133例病理证实的乳腺癌患者,其中低TIL水平73例、高TIL水平60例。
- 在T2WI、DWI及DCE-MRI每一期相上手动勾画乳腺癌病灶体积,共提取6250个定量特征。
- 采用LASSO方法为分类器筛选预测特征集,构建四类模型:单增强期相影像组学模型、融合增强多期相影像组学模型、融合多序列影像组学模型、联合影像组学与临床的模型。
诊断标准与关键数值
- 以病理证实的TIL水平为参考标准,将患者分为低TIL水平73例与高TIL水平60例。
- 延迟期MRI特征(尤其DCE_Phase 6)预测性能优于其他期相特征。
- 融合多序列影像组学模型预测TIL的AUC为0.934;联合影像组学与临床的模型AUC为0.950,两者差异无统计学意义。
临床应用与阅片要点
- 阅片及构建影像组学模型时可优先关注DCE-MRI延迟期图像,其TIL预测价值优于其他期相。
- 融合多序列影像组学特征或联合临床信息的列线图可用于乳腺癌TIL水平的无创预测。
局限性
- 本研究为回顾性设计。
- 单中心样本量有限(133例)。
- 原文未报告外部验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To systematically investigate the effect of imaging features at different DCE-MRI phases to optimise a radiomics model based on DCE-MRI for the prediction of tumour-infiltrating lymphocyte (TIL) levels in breast cancer.
MATERIALS AND METHODS: This study retrospectively collected 133 patients with pathologically proven breast cancer, including 73 patients with low TIL levels and 60 patients with high TIL levels. The volumes of breast cancer lesions were manually delineated on T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), and each phase of DCE-MRI, followed by 6250 quantitative feature extractions. The least absolute shrinkage and selection operator (LASSO) method was used to select predictive feature sets for the classifiers. Four models were developed for predicting TILs: (1) single enhanced phase radiomics models; (2) fusion enhanced multi-phase radiomics models; (3) fusion multi-sequence radiomics models; and (4) a combined radiomics-based clinical model.
RESULTS: Image features extracted from the delayed phase MRI, especially DCE_Phase 6 (DCE_P6), demonstrated dominant predictive performances over features from other phases. The fusion multi-sequence radiomics model and combined radiomics-based clinical model achieved the highest predictive performances with areas under the curve (AUCs) of 0.934 and 0.950, respectively; however, the differences were not statistically significant.
CONCLUSION: The DCE-MRI radiomics model, especially image features extracted from the delayed phases, can help improve the performance in predicting TILs. The radiomics nomogram is effective in predicting TILs in breast cancer.
KEY POINTS: • Radiomics features extracted from DCE-MRI, especially delayed phase images, help predict TIL levels in breast cancer. • We developed a nomogram based on MRI to predict TILs in breast cancer that achieved the highest AUC of 0.950.
引用
- Tang WJ, Kong QC, Cheng ZX, et al. Performance of radiomics models for tumour-infiltrating lymphocyte (TIL) prediction in breast cancer: the role of the dynamic contrast-enhanced (DCE) MRI phase. Eur Radiol. 2021. PMID: 34430998. doi:10.1007/s00330-021-08173-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。